Caragh P. Stapleton

726 total citations
9 papers, 125 citations indexed

About

Caragh P. Stapleton is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Caragh P. Stapleton has authored 9 papers receiving a total of 125 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Nephrology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in Caragh P. Stapleton's work include Renal Diseases and Glomerulopathies (4 papers), Nonmelanoma Skin Cancer Studies (2 papers) and Genomics and Rare Diseases (1 paper). Caragh P. Stapleton is often cited by papers focused on Renal Diseases and Glomerulopathies (4 papers), Nonmelanoma Skin Cancer Studies (2 papers) and Genomics and Rare Diseases (1 paper). Caragh P. Stapleton collaborates with scholars based in Ireland, United States and United Kingdom. Caragh P. Stapleton's co-authors include Peter J. Conlon, Gianpiero L. Cavalleri, Paul J. Phelan, Claire Kennedy, Howard L. Kaplan, Brendan J. Keating, Michael Spino, Edward M. Sellers, S Macleod and Susan Murray and has published in prestigious journals such as American Journal of Transplantation, Frontiers in Pharmacology and American Journal of Nephrology.

In The Last Decade

Caragh P. Stapleton

9 papers receiving 120 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Caragh P. Stapleton Ireland	7	47	30	25	22	21	9	125
Simone Wygoda Germany	7	43 0.9×	17 0.6×	8 0.3×	26 1.2×	27 1.3×	8	102
R. Goldschmeding Netherlands	4	25 0.5×	46 1.5×	13 0.5×	3 0.1×	17 0.8×	6	130
Tim Prestidge New Zealand	6	18 0.4×	6 0.2×	10 0.4×	38 1.7×	13 0.6×	8	116
Melissa Muff‐Luett United States	5	63 1.3×	31 1.0×	12 0.5×	11 0.5×	10 0.5×	12	124
Albane Brodin-Sartorius France	6	22 0.5×	13 0.4×	6 0.2×	16 0.7×	18 0.9×	8	215
Alexis Wérion Belgium	9	78 1.7×	35 1.2×	6 0.2×	17 0.8×	5 0.2×	15	173
Christine B. Sethna United States	6	62 1.3×	17 0.6×	7 0.3×	17 0.8×	5 0.2×	12	106
Daniella Magen Israel	3	170 3.6×	74 2.5×	55 2.2×	5 0.2×	7 0.3×	4	222
D. W. Bowden United States	6	59 1.3×	41 1.4×	31 1.2×	6 0.3×	15 0.7×	7	142
Daniel Ranch United States	6	97 2.1×	36 1.2×	51 2.0×	10 0.5×	14 0.7×	12	137

Countries citing papers authored by Caragh P. Stapleton

Since Specialization

Citations

This map shows the geographic impact of Caragh P. Stapleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caragh P. Stapleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caragh P. Stapleton more than expected).

Fields of papers citing papers by Caragh P. Stapleton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caragh P. Stapleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caragh P. Stapleton. The network helps show where Caragh P. Stapleton may publish in the future.

Co-authorship network of co-authors of Caragh P. Stapleton

This figure shows the co-authorship network connecting the top 25 collaborators of Caragh P. Stapleton. A scholar is included among the top collaborators of Caragh P. Stapleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caragh P. Stapleton. Caragh P. Stapleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Wolking, Stefan, Ciarán Campbell, Caragh P. Stapleton, et al.. (2021). Role of Common Genetic Variants for Drug-Resistance to Specific Anti-Seizure Medications. Frontiers in Pharmacology. 12. 688386–688386. 15 indexed citations

2.

Stapleton, Caragh P., Bao‐Li Chang, Brendan J. Keating, Peter J. Conlon, & Gianpiero L. Cavalleri. (2020). Polygenic risk score of non‐melanoma skin cancer predicts post‐transplant skin cancer across multiple organ types. Clinical Transplantation. 34(8). e13904–e13904. 10 indexed citations

3.

Murray, Susan, Anthony Dorman, Katherine A. Benson, et al.. (2019). Utility of Genomic Testing after Renal Biopsy. American Journal of Nephrology. 51(1). 43–53. 19 indexed citations

4.

Stapleton, Caragh P., Claire Kennedy, Susan Murray, et al.. (2019). An Exome Sequencing Study of 10 Families with IgA Nephropathy. The Nephron journals/Nephron journals. 144(2). 72–83. 13 indexed citations

5.

Stapleton, Caragh P., Kelly A. Birdwell, Amy Jayne McKnight, et al.. (2018). Polygenic risk score as a determinant of risk of non-melanoma skin cancer in a European-descent renal transplant cohort. American Journal of Transplantation. 19(3). 801–810. 27 indexed citations

6.

Kennedy, Claire, Dervla M. Connaughton, Caragh P. Stapleton, et al.. (2018). Clinical Heterogeneity in Familial IgA Nephropathy. The Nephron journals/Nephron journals. 139(1). 63–69. 6 indexed citations

7.

Stapleton, Caragh P., Peter J. Conlon, & Paul J. Phelan. (2017). Using omics to explore complications of kidney transplantation. Transplant International. 31(3). 251–262. 14 indexed citations

8.

Awan, Atif, et al.. (2016). Clinical manifestations of prune belly syndrome. Clinical Medicine. 16(3). s5–s5. 2 indexed citations

9.

Spino, Michael, Edward M. Sellers, Howard L. Kaplan, Caragh P. Stapleton, & S Macleod. (1978). Adverse biochemical and clinical consequences of furosemide administration.. PubMed. 118(10). 1169–70. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact